Should interferons take front stage as an essential MS disease-modifying therapy in the era of coronavirus disease 2019?
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7309524/ https://www.ncbi.nlm.nih.gov/pubmed/32527763 http://dx.doi.org/10.1212/NXI.0000000000000811 |